Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

The Big Spend-Down: US FDA Eyes $159M Reduction In Carryover User Fees

Apr 08 2018

• By Sue Sutter and Derrick Gingery

Woman counting dollars at table

Related Content

FDA May Not Implement User Fee Workload Adjuster In PDUFA VI

Apr 02 2018

FDA's GDUFA War Chest Grows, And Industry May Look For Lower Fees

Jun 08 2015

PDUFA VI Might Adjust Establishment Fees; FDA Aims For Simplification

Nov 16 2015

21st Century Cures Now A Partially Funded Mandate For FDA

May 21 2015

Biosimilar User Fee Collections Rise, But Little Spent On Program Costs

Apr 25 2016

Biosimilar User Fee Agreement Offers FDA Funding Boost, Fee Structure Overhaul

Sep 17 2016

Hamburg, Like Industry, Wants Predictability – But In FDA Funding

Nov 06 2013

Additional Topics

United States Drug Review Generic Drugs Biosimilars FDA Policy BioPharmaceutical

More from Generics

More from Products

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window